SCHEMBL524712

SCHEMBL524712

COc1cc(C=O)cc(Br)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
MAPK1 P28482 2/20 0.63
TUBB1 Q9H4B7 4/20 0.58
TUBB4A P04350 2/20 0.58
TUBB P07437 2/20 0.58
TUBA3C P0DPH7 2/20 0.58
TUBA1B P68363 2/20 0.58
TUBA4A P68366 2/20 0.58
TUBB4B P68371 2/20 0.58
TUBB3 Q13509 2/20 0.58
TUBB2A Q13885 2/20 0.58
TUBB8 Q3ZCM7 2/20 0.58
TUBA3E Q6PEY2 2/20 0.58
TUBA1A Q71U36 2/20 0.58
TUBA1C Q9BQE3 2/20 0.58
TUBB6 Q9BUF5 2/20 0.58
TUBB2B Q9BVA1 2/20 0.58
TNFRSF1A P19438 3/20 0.56
TSHR P16473 2/20 0.50
HTT P42858 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30122857 1.00 ALDH1A1 (0.63) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL14958356 0.98 ALDH1A1 (0.61) ALDH1A1MAPK1TUBB1TUBB4ATUBB
Hydrazine SCHEMBL14954414 0.95 ALDH1A1 (0.62) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL21694048 0.90 ALDH1A1 (0.58) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL2588646 0.88 MAPT (0.55) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL16619850 0.86 ALDH1A1 (0.59) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL96635 0.86 ALDH1A1 (0.59) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL15961199 0.85 ALDH1A1 (0.50) ALDH1A1MAPK1TUBB1TUBB4ATUBB
SCHEMBL14835707 0.84 ALDH1A1 (0.68) ALDH1A1MAPK1TUBB1TUBB4ATUBB
Hydrochloric Acid SCHEMBL23711567 0.84 ALDH1A1 (0.57) ALDH1A1MAPK1TUBB1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115463119-A VEGFR-2 inhibitor and preparation and application thereof 青岛科技大学 2022-12-13 CN claimed
CN-106278941-A Nine kinds of PTP1B inhibitor and synthesis thereof and application 南通中国科学院海洋研究所海洋科学与技术研究发展中心 2017-01-04 CN claimed
US-8816129-B2 PTP1B inhibitors, synthesis thereof and application thereof in preparation of medicaments for treating type 2 diabetes mellitus INSTITUTE OF OCEANOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2014-08-26 US claimed
CN-103601688-A Synthetic method of trimethoprim impurity UNIV SICHUAN 2014-02-26 CN claimed
US-20130131182-A1 PTP1B INHIBITORS, SYNTHESIS THEREOF AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR TREATING TYPE 2 DIABETES MELLITUS INSTITUTE OF OCEANOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2013-05-23 US claimed
CN-101987813-B Chemical total synthesis method for diabetes type II resistant medicament hypnopyrine INST OCEANOLOGY CHINESE ACAD 2013-04-17 CN claimed
CN-102018692-B PTP1B inhibitors and synthesis thereof, and application of PTP1B inhibitors in preparation of medicines for treating type 2 diabetes INST OCEANOLOGY CHINESE ACAD 2012-11-07 CN claimed
CN-102018688-B PTP1B inhibitor and synthesis and application thereof in preparation of medicine used for treating type II diabetes INST OCEANOLOGY CHINESE ACAD 2012-10-10 CN claimed
CN-102020621-B Chemical complete synthesis method of medicine used for treating thrombus heart cerebrovascular disease INST OCEANOLOGY CHINESE ACAD 2012-10-03 CN claimed
CN-102020540-B Three protein tyrosine phosphatase 1B (PTP1B) inhibitors and synthesis and application thereof INST OCEANOLOGY CHINESE ACAD 2012-09-19 CN claimed
CN-102020540-A Three protein tyrosine phosphatase 1B (PTP1B) inhibitors and synthesis and application thereof INST OF OCEANOLOGY OF CHINESE ACADEMY OF SCIENCES 2011-04-20 CN claimed
CN-102018692-A PTP1B inhibitors and synthesis thereof, and application of PTP1B inhibitors to preparation of medicines for treating type 2 diabetes INST OF OCEANOLOGY OF CHINESE ACADEMY OF SCIENCES 2011-04-20 CN claimed
CN-102020621-A Chemical complete synthesis method of medicine used for treating thrombus heart cerebrovascular disease INST OF OCEANOLOGY OF CHINESE ACADEMY OF SCIENCES 2011-04-20 CN claimed
CN-102018688-A PTP1B inhibitor and synthesis and application thereof in preparation of medicine used for treating type II diabetes INST OF OCEANOLOGY OF CHINESE ACADEMY OF SCIENCES 2011-04-20 CN claimed
CN-101987813-A Chemical total synthesis method for type II anti-diabetic medicament hypnopyrine INST OCEANOLOGY CHINESE ACAD 2011-03-23 CN claimed
US-20060084176-A1 Detection of uronium salts YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-04-20 US claimed
US-4380629-A Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) 1983-04-19 US claimed
US-4147862-A Method of preparing styryl-like compounds MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1979-04-03 US claimed
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed
US-3976695-A Halogen substituted α-(aminoalkyl)-3,4-dihydroxybenzyl alcohols SMITHKLINE CORPORATION (US) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131182-A1 PTP1B INHIBITORS, SYNTHESIS THEREOF AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR TREATING TYPE 2 DIABETES MELLITUS PTPA, PPP2CA, PTPRS ALDH1A1 2001/4885MAPK1 901/4885TUBB1 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.